Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT: SIPHA)
Tunisia
· Delayed Price · Currency is TND 4.450
-0.850 (-16.04%)
At close: Dec 18, 2024
BVMT: SIPHA Income Statement
Financials in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '20 Jun 30, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
| Operating Revenue | 17.97 | 22.51 | 31.06 | 35.3 | 40.78 | 42.28 | Upgrade
|
| Other Revenue | 2.25 | 1.89 | 2.13 | 1.99 | 1.8 | 2.5 | Upgrade
|
| Revenue | 20.23 | 24.4 | 33.19 | 37.3 | 42.58 | 44.79 | Upgrade
|
| Revenue Growth (YoY) | -35.11% | -26.47% | -11.00% | -12.41% | -4.93% | 8.82% | Upgrade
|
| Cost of Revenue | 11.03 | 15.38 | 21.08 | 20.11 | 20.09 | 20.95 | Upgrade
|
| Gross Profit | 9.19 | 9.03 | 12.11 | 17.19 | 22.48 | 23.84 | Upgrade
|
| Selling, General & Admin | 18.52 | 18.42 | 18.29 | 18.48 | 19.53 | 19.74 | Upgrade
|
| Other Operating Expenses | 3.2 | 2.74 | 1.93 | 1.93 | 2.59 | 2.67 | Upgrade
|
| Operating Expenses | 23.11 | 22.68 | 22.15 | 22.53 | 24.43 | 24.99 | Upgrade
|
| Operating Income | -13.92 | -13.65 | -10.04 | -5.34 | -1.94 | -1.16 | Upgrade
|
| Interest Expense | -1.96 | -1.81 | -1.34 | -1.01 | -0.74 | -0.96 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.12 | 0.05 | 0.03 | 0.02 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.55 | 0.77 | -1.98 | -1.16 | -1.59 | -0.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.3 | 0.11 | -0.93 | -0.06 | 0.22 | 0.11 | Upgrade
|
| EBT Excluding Unusual Items | -17.12 | -14.47 | -14.25 | -7.54 | -4.03 | -2.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.12 | - | -0.43 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.06 | - | 0.36 | 0.05 | Upgrade
|
| Asset Writedown | 0.06 | - | -0 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | 0.03 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.01 | -0.04 | Upgrade
|
| Pretax Income | -17.06 | -14.47 | -14.2 | -7.66 | -3.68 | -2.75 | Upgrade
|
| Income Tax Expense | 0.04 | 0.05 | 0.07 | 0.08 | 0.09 | 0.09 | Upgrade
|
| Earnings From Continuing Operations | -17.1 | -14.52 | -14.27 | -7.73 | -3.77 | -2.85 | Upgrade
|
| Net Income | -17.1 | -14.52 | -14.27 | -7.73 | -3.77 | -2.85 | Upgrade
|
| Net Income to Common | -17.1 | -14.52 | -14.27 | -7.73 | -3.77 | -2.85 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | - | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | - | Upgrade
|
| EPS (Basic) | -9.50 | -8.07 | -7.93 | -4.30 | -2.09 | - | Upgrade
|
| EPS (Diluted) | -9.50 | -8.07 | -7.93 | -4.30 | -2.09 | - | Upgrade
|
| Free Cash Flow | -15.37 | -6.77 | 2.5 | -2.95 | 1.65 | 3.04 | Upgrade
|
| Free Cash Flow Per Share | -8.54 | -3.76 | 1.39 | -1.64 | 0.92 | - | Upgrade
|
| Gross Margin | 45.45% | 36.99% | 36.48% | 46.08% | 52.81% | 53.22% | Upgrade
|
| Operating Margin | -68.83% | -55.94% | -30.26% | -14.32% | -4.56% | -2.58% | Upgrade
|
| Profit Margin | -84.57% | -59.52% | -42.98% | -20.74% | -8.85% | -6.35% | Upgrade
|
| Free Cash Flow Margin | -75.99% | -27.73% | 7.52% | -7.91% | 3.88% | 6.80% | Upgrade
|
| EBITDA | -12.53 | -12.13 | -8.11 | -3.22 | 0.37 | 1.43 | Upgrade
|
| EBITDA Margin | -61.96% | -49.70% | -24.43% | -8.64% | 0.86% | 3.18% | Upgrade
|
| D&A For EBITDA | 1.39 | 1.52 | 1.93 | 2.12 | 2.31 | 2.58 | Upgrade
|
| EBIT | -13.92 | -13.65 | -10.04 | -5.34 | -1.94 | -1.16 | Upgrade
|
| EBIT Margin | -68.83% | -55.94% | -30.26% | -14.32% | -4.56% | -2.58% | Upgrade
|
| Revenue as Reported | 20.27 | 24.46 | 33.15 | 37.37 | 42.65 | 44.84 | Upgrade
|
| Advertising Expenses | - | 0.17 | 0.36 | 0.37 | 0.52 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.